Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Clinical trial NCT02278991 · COMPLETED

Trial details

NCT number: NCT02278991
Sponsor: C. R. Bard
Status: COMPLETED
Study type: OBSERVATIONAL

Peripheral Artery Disease

Start date: 2014-10-01
Primary completion: 2017-09-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.